Atreca

+$0.58 (+11.81%) Today
+$0.03 (+0.55%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atreca and other ETFs, options, and stocks.

About BCEL

Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response.

CEO
John A. Orwin
Employees
130
Headquarters
San Carlos, California
Founded
2010

BCEL Key Statistics

Market Cap
392.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.84M
High Today
$5.75
Low Today
$4.80
Open Price
$4.90
Volume
3.67M
52 Week High
$20.29
52 Week Low
$4.80

BCEL News

BenzingaJul 29

Mid-Day Market Update: LendingClub Surges Following Strong Q2 Results; Atreca Shares Plummet

Midway through trading Thursday, the Dow traded up 0.55% to 35,122.75 while the NASDAQ rose 0.47% to 14,831.28. The S&P also rose, gaining 0.61% to 4,427.36. T

BCEL Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure